These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 7269732

  • 1. [Clinical-electrophysiological study of the effect of lorcainide on induction of ventricular tachycardia (author's transl)].
    Breithardt G, Seipel L, Abendroth RR.
    Z Kardiol; 1981 Jul; 70(7):530-5. PubMed ID: 7269732
    [Abstract] [Full Text] [Related]

  • 2. [Electrophysiological effects of flecainide on stimulus-inducible ventricular tachycardia].
    Breithardt G, Borggrefe M, Yeh HL, Seipel L.
    Z Kardiol; 1982 Apr; 71(4):278-83. PubMed ID: 7090468
    [Abstract] [Full Text] [Related]

  • 3. Treatment with oral lorcainide in patients with sustained ventricular tachycardia and fibrillation.
    Echt DS, Shapiro M, Trusso J, Mason JW, Winkle RA.
    Am Heart J; 1985 Jan; 109(1):28-33. PubMed ID: 3966329
    [Abstract] [Full Text] [Related]

  • 4. Lorcainide for the treatment of refractory ventricular tachycardia: clinical and electrophysiologic results.
    Hanyok JJ, Kluger J, Chow MS, Fieldman A.
    J Clin Pharmacol; 1987 Apr; 27(4):278-82. PubMed ID: 3680584
    [Abstract] [Full Text] [Related]

  • 5. [Response of ventricular late potentials after surgical therapy of ventricular tachycardia].
    Breithardt G, Borggrefe M, Karbenn U, Ostermeyer J, Abendroth RR, Yeh HL, Seipel L.
    Z Kardiol; 1982 Jun; 71(6):381-6. PubMed ID: 6981888
    [Abstract] [Full Text] [Related]

  • 6. Antiarrhythmic effect of lorcainide during chronic treatment.
    Meinertz T, Kasper W, Kersting F, Bechtold H, Just H, Jähnchen E.
    Arzneimittelforschung; 1980 Jun; 30(9):1593-5. PubMed ID: 7193031
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Antiarrhythmia effectiveness of oral sotalol in patients with coronary heart disease and ventricular tachycardias].
    Trappe HJ, Klein H, Lichtlen PR.
    Z Kardiol; 1987 Oct; 76(10):630-4. PubMed ID: 3687165
    [Abstract] [Full Text] [Related]

  • 9. Long term lorcainide therapy guided by electrophysiology studies.
    Somberg J, Butler B, Flowers D, Tepper D, Torres V.
    Acta Cardiol; 1985 Oct; 40(6):621-36. PubMed ID: 3879419
    [Abstract] [Full Text] [Related]

  • 10. Comparison of noninvasive arrhythmia induction techniques with electrophysiologic studies and evaluation of lorcainide in patients with symptomatic ventricular tachycardia.
    Somberg JC, Butler B, Flowers D, Tepper D, Maguire W, Willens H, Keren G, Miura D.
    Am J Cardiol; 1984 Aug 13; 54(4):49B-54B. PubMed ID: 6465047
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of ventricular tachycardia with propafenone. Parallel study of ventricular provocation tests].
    Faućhier JP, Rouesnel P, Cosnay P, Moquet B, Huguet R, Van Viet H, Balleh H.
    Arch Mal Coeur Vaiss; 1987 Sep 13; 80(10):1523-31. PubMed ID: 3125812
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F, Rolli A, Carboni A, Finardi A, Aurier E, Favaro L, Contini S, Gherli T, Caponi D, Maranga SS, Lepera G, Bartoletti A.
    G Ital Cardiol; 1999 Oct 13; 29(10):1142-56. PubMed ID: 10546124
    [Abstract] [Full Text] [Related]

  • 14. Dose-related shortening of ventricular tachycardia cycle length after administration of the KATP channel opener bimakalim in a 4-day-old chronic infarct anesthetized pig model.
    Aidonidis I, Poyatzi A, Stamatiou G, Lymberi M, Stamatoyannis N, Molyvdas PA.
    J Cardiovasc Pharmacol Ther; 2009 Sep 13; 14(3):222-30. PubMed ID: 19587223
    [Abstract] [Full Text] [Related]

  • 15. Spatial dispersion of action potential duration restitution kinetics is associated with induction of ventricular tachycardia/fibrillation in humans.
    Pak HN, Hong SJ, Hwang GS, Lee HS, Park SW, Ahn JC, Moo Ro Y, Kim YH.
    J Cardiovasc Electrophysiol; 2004 Dec 13; 15(12):1357-63. PubMed ID: 15610278
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of lorcainide in patients with symptomatic ventricular tachycardia.
    Somberg JC, Butler B, Flowers D, Keefe D, Torres V, Miura D.
    Am J Cardiol; 1984 Aug 13; 54(4):43B-48B. PubMed ID: 6465046
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lorcainide therapy for the high-risk patient post myocardial infarction.
    Somberg JC, Butler B, Torres V, Flowers D, Tepper D, Keefe D, Miura DS.
    Am J Cardiol; 1984 Aug 13; 54(4):37B-42B. PubMed ID: 6465045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.